EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit ...
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Kepler Capital Sticks to Their Buy Rating for MaaT Pharma (MAAT)
Kepler Capital analyst Christophe dombu maintained a Buy rating on MaaT Pharma (MAAT – Research Report) on March 12 and set a price target of ...